Patents Assigned to LIQUID BIOSCIENCE, INC.
  • Patent number: 11208694
    Abstract: Response to treatment of an inflammatory condition can be predicted based on characteristics of one or more markers from a subject. The markers can include expressions of nucleotide sequences identified herein and of combinations thereof. A response value can be calculated based on characteristics (e.g., expression levels) of one or more of the markers, as well as other characteristics of the subject, such as baseline clinical data. The treatment can be administered when the response value is beyond a threshold.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 28, 2021
    Assignee: LIQUID BIOSCIENCE, INC.
    Inventors: Patrick Lilley, Matthew Nunez